Monte Rosa Therapeutics, Inc.
GLUE$1.25B
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaBOSTON147 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
May 15, 2026
8wMarket Overview
Stock performance and key metrics
GLUE News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Oral MRT-2359 | Phase 2 | NSCLC | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply